Author of the publication

Overexpression of beta-arrestin and beta-adrenergic receptor kinase augment desensitization of beta 2-adrenergic receptors

, , , , , , and . J Biol Chem, 268 (5): 3201-8 (February 1993)Pippig, S Andexinger, S Daniel, K Puzicha, M Caron, M G Lefkowitz, R J Lohse, M J Research Support, Non-U.S. Gov't United states The Journal of biological chemistry J Biol Chem. 1993 Feb 15;268(5):3201-8..

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Phosducin is a protein kinase A-regulated G-protein regulator, , , , , , and . Nature, 358 (6381): 73-6 (July 1992)Bauer, P H Muller, S Puzicha, M Pippig, S Obermaier, B Helmreich, E J Lohse, M J Research Support, Non-U.S. Gov't England Nature Nature. 1992 Jul 2;358(6381):73-6..Overexpression of beta-arrestin and beta-adrenergic receptor kinase augment desensitization of beta 2-adrenergic receptors, , , , , , and . J Biol Chem, 268 (5): 3201-8 (February 1993)Pippig, S Andexinger, S Daniel, K Puzicha, M Caron, M G Lefkowitz, R J Lohse, M J Research Support, Non-U.S. Gov't United states The Journal of biological chemistry J Biol Chem. 1993 Feb 15;268(5):3201-8..Mechanism of inhibition of Raf-1 by protein kinase A, , , , , , , , , and . Mol Cell Biol, 14 (10): 6696-703 (October 1994)Hafner, S Adler, H S Mischak, H Janosch, P Heidecker, G Wolfman, A Pippig, S Lohse, M Ueffing, M Kolch, W United states Molecular and cellular biology Mol Cell Biol. 1994 Oct;14(10):6696-703..Sequestration and recycling of beta 2-adrenergic receptors permit receptor resensitization, , and . Mol Pharmacol, 47 (4): 666-76 (April 1995)Pippig, S Andexinger, S Lohse, M J Research Support, Non-U.S. Gov't United states Molecular pharmacology Mol Pharmacol. 1995 Apr;47(4):666-76..Clinical relevance of urokinase-type plasminogen activator and its inhibitor type 1 (PAI-1) in squamous cell carcinoma of the uterine cervix, , , , , , and . The Australian & New Zealand journal of obstetrics & gynaecology, 42 (4): 383–386 (2002)